Upper Palace
Natural health product licensed in Canada
- Other names
- Kan - Upper Palace
- Licence holder
- Natural Path Herb Company
- NPN or DIN-HM
- 80116305
- Status
- Active licence
- Licence date
- 10 February 2022
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Platycodon grandiflorus (Jacq.) A.DC.: L'étiquetage doit comporter un avertissement déconseillant un usage prolongé, tel que "L'usage prolongé peut irriter l'estomac".
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Cyathula officinalis K.C.Kuan: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Platycodon grandiflorus | 30 mg | Not calculated |
| Cyathula officinalis | 60 mg | Not calculated |
| Rehmannia glutinosa | 60 mg | Not calculated |
| Bupleurum chinense | 20 mg | Not calculated |
| Paeonia anomala subsp. veitchii Source : Paeonia anomala subsp. veitchii - Racine | 40 mg | Not calculated |
| Ligusticum sinense cv. chuanxiong Source : Ligusticum sinense cv. chuanxiong - Rhizome | 30 mg | Not calculated |
| Angelica sinensis Source : Angelica sinensis - Racine | 60 mg | Not calculated |
| Glycyrrhiza uralensis | 20 mg | Not calculated |
| Carthamus tinctorius Source : Carthamus tinctorius - Fleur | 60 mg | Not calculated |
| Prunus persica Source : Prunus davidiana - Graine | 80 mg | Not calculated |
| Citrus aurantium Source : Citrus aurantium - fruit | 40 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Acide stéarique, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | minimum: 1 day ; maximum: 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Combination of Traditional Chinese Medicine Ingredients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80116305
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.